Search Optiflow FAQs

Is nasal high flow recommended for the treatment of COVID-19?

This FAQ is taken from Flow matters COVID-19 edition, updated Feb 2022. Read the complete edition here. 

Yes.

Nasal high flow use on COVID-19 patients has been observed to:

  • Keep patients off mechanical ventilation and help them stay off.
  • Lower the rate of mortality.
  • Be successfully used outside of ICU settings
  • Reduce the length of stay.


“[NHF] use is associated with a reduction in the rate of invasive mechanical ventilation and overall mortality in patients with COVID-19 infection.” - Patel et al. 2020.


The number of organizations that have published evidence-based guidelines recommending the use of NHF for COVID-19 patients continues to grow:

  • World Health Organisation
  • National Institutes of Health
  • National Health Commission of the Peoples Republic of China
  • Surviving Sepsis Campaign
  • Australia and New Zealand Intensive Care Society
  • European Respiratory Society
  • International expert consensus statement
  • Expert recommendations from a French panel consisting of members from various intensive care societies

 

Flow Matters Edition 10
Read more here. (includes all references) 
 

You might also be interested in:

 
 
PM-622638_a

We value your privacy. Our websites and applications use cookies to function properly and securely. 

De-identified Information, as described in our Global Privacy Statement, may be collected and used to support the performance of these sites, and to provide you with a better user experience. Cookie information is not used to promote personalised content on our websites. To learn more about how we use cookies, including examples, go to our Global Privacy Statement.